Inventurus Knowledge Solutions Ltd
Inventurus Knowledge Solutions Ltd (IKS Health) has launched its Initial Public Offering (IPO), attracting significant attention from investors. Below is a comprehensive overview of the IPO details:
Introduction
Inventurus Knowledge Solutions Ltd, a prominent healthcare technology company, is offering its shares to the public through an IPO. The subscription period is from December 12 to December 16, 2024. The company aims to raise approximately ₹2,497.92 crore through this offering.
Company Overview
Founded in 2006, Inventurus Knowledge Solutions Ltd provides technology-enabled healthcare solutions, focusing on outpatient and inpatient care organizations primarily in the United States, Canada, and Australia. The company’s platform assists healthcare providers in delivering clinical care, improving population health outcomes, and transitioning to value-based care models. As of March 2024, IKS Health has partnered with over 800 healthcare organizations, including health systems, academic medical centers, and multi-specialty medical groups.
IPO Timeline
- IPO Open Date: December 12, 2024
- IPO Close Date: December 16, 2024
- Basis of Allotment Date: December 17, 2024
- Initiation of Refunds: December 18, 2024
- Credit of Shares to Demat Accounts: December 18, 2024
- Listing Date: December 19, 2024
Price Band and Lot Size
- Price Band: ₹1,265 to ₹1,329 per share
- Lot Size: 11 shares per lot
- Minimum Investment: ₹14,619
Financials
The company’s financial performance over the past three fiscal years is as follows:
| Fiscal Year | Revenue (₹ crore) | Profit After Tax (₹ crore) |
|---|---|---|
| FY 2022 | 763.63 | 232.97 |
| FY 2023 | 1,031.30 | 305.23 |
| FY 2024 | 1,817.93 | 370.49 |
Strengths
- Robust Revenue Growth: The company has demonstrated a strong revenue growth trajectory, with a compound annual growth rate (CAGR) of 54.3% between FY 2022 and FY 2024.
- Diverse Client Base: Partnerships with over 800 healthcare organizations enhance its market presence.
- Technological Expertise: Focus on advanced technology solutions, including AI and automation, to improve efficiency.
Risks
- Market Concentration: Significant reliance on the U.S. market may pose risks due to regulatory changes.
- Competitive Industry: The healthcare technology sector is highly competitive, with rapid technological advancements.
IPO Anchor Investors Details
Prior to the IPO, Inventurus Knowledge Solutions Ltd raised ₹1,120 crore from anchor investors by allotting 84.28 lakh shares at ₹1,329 per share. Domestic mutual funds accounted for 33.33% of the total allocation through 12 funds across 23 schemes.
IPO Promoter Holding
| Promoter | Pre-Issue Holding | Post-Issue Holding |
|---|---|---|
| Sachin Gupta | Data not specified | Data not specified |
| Rekha Jhunjhunwala | 0.23% | Data not specified |
| Aryaman Jhunjhunwala Discretionary Trust | Data not specified | Data not specified |
| Aryavir Jhunjhunwala Discretionary Trust | Data not specified | Data not specified |
| Nishtha Jhunjhunwala Discretionary Trust | Data not specified | Data not specified |
IPO Grey Market Premium (GMP)
As of December 15, 2024, the Grey Market Premium for the IKS IPO is ₹405 per share, indicating a potential listing price of ₹1,734 per share, which is approximately 30.47% above the upper price band of ₹1,329.
Final Thoughts
Inventurus Knowledge Solutions Ltd’s IPO presents an opportunity to invest in a rapidly growing healthcare technology company with a strong financial track record and a diverse client base. However, potential investors should consider market concentration risks and industry competition before making investment decisions.